2014 was a boon for mergers and acquisitions but some think that if the Fed starts tightening, it will end. Not so, says Jim Cramer.
Gilead shares have had a tremendous run this year, but the valuation remains cheap considering its sales potential in the area of Hepatitis C.
Markets brace for action in the Week Ahead as the calendar is packed with domestic and global economic data and earnings.
Healthcare supplies sales and organic growth around the world lifted 3M earnings in the third quarter.
Investors should remain diversified and conservative in the face of elevated volatility in coming months, according to American Century Investments' David MacEwen.
Young investors have the advantage of a long time horizon so they should buy beaten-down value stocks as opposed to high multiple growth names.
Breakout Stocks Portfolio Manager Bryan Ashenberg, CFA offers viewers his take on Mobile Mini and why he believes investors should consider the stock for investment.
WBI Investments is rolling out a full suite of exchange traded funds to offer an actively managed, globally opportunistic investment option, says the company's President Matt Schreiber.
US Silica shares will continue to climb as fracking in the US continues to see double digit growth, said Jason Schrotberger, portfolio manager for the Turner Small Cap Growth Fund.
Trifecta Stocks Portfolio Manager Bryan Ashenberg, CFA offers viewers his current take on Monster Beverage (MNST).